Estructura del grupo
18 empresas en 7 países
Cargando…
18 empresas en 7 países
Una cuenta gratuita para las apps de Prognia: Ward para estudiar, Osler para respuestas clínicas con sus fuentes y la red para encontrar a tus colegas.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Todos los medicamentos de todas las empresas del grupo, primero los vigentes.
1–25 de 114
| Medicamento | Principio activo | País | Estado | Autorización |
|---|---|---|---|---|
| Abirateron MSN 250 mg filmom obložene tableteFilmom obložena tableta | Abiraterone | Croacia | Autorizado | 2024 |
| Abirateron MSN 500 mg filmom obložene tableteFilmom obložena tableta | Abiraterone | Croacia | Comercializado | 2024 |
| AZACITIDINE FOR INJECTION100 mg / vial · Powder For Suspension | Azacitidine | Canadá | Autorizado | |
| Bosutinib MSN 100 mg filmom obložene tableteFilmom obložena tableta | Bosutinib | Croacia | No comercializado | 2025 |
| Bosutinib MSN 400 mg filmom obložene tableteFilmom obložena tableta | Bosutinib | Croacia | No comercializado | 2025 |
| Bosutinib MSN 500 mg filmom obložene tableteFilmom obložena tableta | Bosutinib | Croacia | No comercializado | 2025 |
| BRIVARACETAM10mg/ml · Solution | Brivaracetam | Estados Unidos | Comercializado | 2026 |
| Clizay 100 mg filmom obložene tableteFilmom obložena tableta | Brivaracetam | Croacia | No comercializado | 2026 |
| Clizay 25 mg filmom obložene tableteFilmom obložena tableta | Brivaracetam | Croacia | No comercializado | 2026 |
| Clizay 50 mg filmom obložene tableteFilmom obložena tableta | Brivaracetam | Croacia | No comercializado | 2026 |
| DAPAGLIFLOZIN AND SAXAGLIPTIN HYDROCHLORIDE10mg; 5mg base · Tablet | Dapagliflozin, Saxagliptin | Estados Unidos | Comercializado | 2026 |
| Daplemsen 10 mg filmom obložene tableteFilmom obložena tableta | Dapagliflozin | Croacia | No comercializado | 2026 |
| Daplemsen 5 mg filmom obložene tableteFilmom obložena tableta | Dapagliflozin | Croacia | No comercializado | 2026 |
| DEXRAZOXANE HYDROCHLORIDE250mg base/vial | 500mg base/vial · Injectable | Dexrazoxane | Estados Unidos | Comercializado | 2004 |
| Dimetilfumarat MSN 120 mg tvrde želučanootporne kapsuleŽelučanootporna kapsula, tvrda | Dimethyl | Croacia | Comercializado | 2024 |
| Dimetilfumarat MSN 240 mg tvrde želučanootporne kapsuleŽelučanootporna kapsula, tvrda | Dimethyl | Croacia | Comercializado | 2024 |
| Eltrombopag MSN 25 mg filmom obložene tableteFilmom obložena tableta | Eltrombopag | Croacia | No comercializado | 2025 |
| Eltrombopag MSN 50 mg filmom obložene tableteFilmom obložena tableta | Eltrombopag | Croacia | No comercializado | 2025 |
| Eltrombopag MSN 75 mg filmom obložene tableteFilmom obložena tableta | Eltrombopag | Croacia | No comercializado | 2025 |
| Eplerenon MSN 25 mg filmom obložene tableteFilmom obložena tableta | Eplerenone | Croacia | Comercializado | 2026 |
| Eplerenon MSN 50 mg filmom obložene tableteFilmom obložena tableta | Eplerenone | Croacia | Comercializado | 2026 |
| IRBESARTAN150mg | 300mg | 75mg · Tablet | Irbesartan | Estados Unidos | Comercializado | 2012 |
| Isovurex 10 mg tableteTableta | Ezetimiba | Croacia | Autorizado | 2024 |
| IVABRADINE HYDROCHLORIDE5mg base | 7.5mg base · Tablet | Ivabradine | Estados Unidos | Comercializado | 2021 |
| Jesoxade 10 mg filmom obložene tableteFilmom obložena tableta | Macitentan | Croacia | Comercializado | 2026 |
Dónde es titular o fabricante de medicamentos, y cuántos están vigentes.
| País | Medicamentos | Vigentes | Anteriores | Empresas |
|---|---|---|---|---|
| Croacia | 56 | 56 | 0 | EmpresasTodos los medicamentos |
| Arabia Saudí | 29 | 29 | 0 | EmpresasTodos los medicamentos |
| Estados Unidos | 26 | 13 | 13 | EmpresasTodos los medicamentos |
| Colombia | 2 | 0 | 2 | EmpresasTodos los medicamentos |
| Canadá | 1 | 1 | 0 | EmpresasTodos los medicamentos |
También en los registros de Brasil, Malasia, Reino Unido, Serbia, Singapur, Suecia
Los grupos ATC a los que pertenecen la mayoría de sus medicamentos, de mayor a menor.
Los principios activos presentes en la mayoría de sus medicamentos.
Cómo lo escriben los registros, normalizado: sin forma jurídica, tildes ni mayúsculas.
Recopilado por Prognia a partir de los registros públicos de medicamentos y empresas que aparecen abajo. No se usan logotipos.
Prognia forma los grupos a partir de los nombres que publican las autoridades reguladoras y de los vínculos entre empresas; no son una estructura societaria oficial.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licencia: Public domain (U.S. Government work)
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licencia: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licencia: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licencia: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros, dataset spzp-dfuc, rowsUpdatedAt 1792152828, acquired 2026-10-26; original values retained.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licencia: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licencia: CC BY-SA 4.0
Informa de un error o solicita la retiradaLas correcciones de la propia empresa son bienvenidas.
Mantenga correctos los medicamentos de MSN en Prognia, vea cómo los consultan los profesionales y responda a lo que preguntan. Una llamada de 20 minutos, en inglés.
Reservar una llamadaMedicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licencia: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2026; publication updated 7 October 2026; source PDF periods January–September 2026; original bytes acquired 18 October 2026; PDF page/table/exact-authorisation projections by Prognia under OGL v3.0.
Licencia: Open Government Licence v3.0; GOV.UK Crown copyright publication and linked factual MHRA grant registers
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; October 2026 published list; https://assets.publishing.service.gov.uk/media/6ac65fc6f1ba855cc196a8ba/New_Manufacturing_and_Wholesale_Dealer_Licences_-_October_2026.csv; acquired 2026-10-14T16:17:18.644817+00:00; CSV-to-licence-event projections are adaptations under OGL v3.0.
Licencia: Open Government Licence v3.0; Crown copyright MHRA published licence history
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licencia: Otvorena dozvola RH
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licencia: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licencia: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licencia: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licencia: Singapore Open Data Licence
Grupos farmacéuticos conocidos, cada uno con todas sus empresas.